Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZX48
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,511
Award facts
- Contract value 100% obligated
- $2,510.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 by the Defense Logistics Agency on July 24, 2025, for the supply of Exparel 266 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis. Exparel is a liposomal bupivacaine formulation used for infiltration and nerve block anesthesia in surgical settings, reflecting the ongoing pharmaceutical supply needs of Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's substantial single-award IDC with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent contract enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply requirements across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to consistently secure contracts for branded and generic prescription drugs, biologics, and specialized medical consumables across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DB25FZX48?
SPE2DB25FZX48 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FZX48 worth?
The government has obligated $2,511 on SPE2DB25FZX48.
Is contract SPE2DB25FZX48 an order under another contract?
Yes. SPE2DB25FZX48 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX48 competed?
The extent of competition for SPE2DB25FZX48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award